Published in Diabetes Care on February 01, 2002
Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst (2010) 1.47
Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol (2004) 1.41
Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: a contributor to the beneficial effects of coffee on diabetes. PLoS One (2012) 1.33
Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst (2005) 1.30
Effects of caffeinated and decaffeinated coffee on biological risk factors for type 2 diabetes: a randomized controlled trial. Nutr J (2011) 1.16
Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases. Ann Rheum Dis (2007) 1.10
Caffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans. Longev Healthspan (2012) 1.00
Coffee consumption and risk of incident gout in women: the Nurses' Health Study. Am J Clin Nutr (2010) 0.94
Predicting disease risk using bootstrap ranking and classification algorithms. PLoS Comput Biol (2013) 0.94
Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: the Strong Heart Study. Nutr Metab Cardiovasc Dis (2010) 0.94
Neurohumoral stimulation in type-2-diabetes as an emerging disease concept. Cardiovasc Diabetol (2004) 0.92
Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol (2009) 0.90
Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther (2008) 0.89
Caffeine attenuates lipid accumulation via activation of AMP-activated protein kinase signaling pathway in HepG2 cells. BMB Rep (2013) 0.88
Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients. Eur J Epidemiol (2015) 0.86
Effects of 16-week consumption of caffeinated and decaffeinated instant coffee on glucose metabolism in a randomized controlled trial. J Nutr Metab (2012) 0.84
Does long-term coffee intake reduce type 2 diabetes mellitus risk? Diabetol Metab Syndr (2009) 0.80
The effects of a multi-ingredient dietary supplement on body composition, adipokines, blood lipids, and metabolic health in overweight and obese men and women: a randomized controlled trial. J Int Soc Sports Nutr (2014) 0.80
Herbal therapy: A review of emerging pharmacological tools in the management of diabetes mellitus in Africa. Pharmacogn Mag (2015) 0.79
Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). J Clin Oncol (2015) 0.79
Caffeine and insulin resistance in pregnancy. Am J Perinatol (2011) 0.79
Tea and coffee consumption in relation to vitamin D and calcium levels in Saudi adolescents. Nutr J (2012) 0.79
Dietary patterns and bone mineral density in Brazilian postmenopausal women with osteoporosis: a cross-sectional study. Eur J Clin Nutr (2015) 0.78
Caffeine: a cause of insulin resistance? Diabetes Care (2002) 0.78
Chronic caffeine intake reverses age-induced insulin resistance in the rat: effect on skeletal muscle Glut4 transporters and AMPK activity. Age (Dordr) (2012) 0.78
The effect of caffeine on glucose kinetics in humans--influence of adrenaline. J Physiol (2005) 0.78
Caffeine's impairment of insulin-mediated glucose disposal cannot be solely attributed to adrenaline in humans. J Physiol (2007) 0.77
Coffee does not modify postprandial glycaemic and insulinaemic responses induced by carbohydrates. Eur J Nutr (2011) 0.76
Can Tea Consumption be a Safe and Effective Therapy Against Diabetes Mellitus-Induced Neurodegeneration? Curr Neuropharmacol (2014) 0.76
Caffeine modifies blood glucose availability during prolonged low-intensity exercise in individuals with type-2 diabetes. Colomb Med (Cali) (2014) 0.75
Relationship of Caffeine with Adiponectin and Blood Sugar Levels in Subjects with and without Diabetes. J Clin Diagn Res (2015) 0.75
Interaction of physical trainings and coffee intakes in fuel utilization during exercise in rats. Nutr Res Pract (2013) 0.75
Dichotomous effect of caffeine, curcumin, and naringenin on genomic DNA of normal and diabetic subjects. Scientifica (Cairo) (2014) 0.75
Acute caffeine ingestion reduces insulin sensitivity in healthy subjects: a systematic review and meta-analysis. Nutr J (2016) 0.75
Twelve weeks supplementation with an extended-release caffeine and ATP-enhancing supplement may improve body composition without affecting hematology in resistance-trained men. J Int Soc Sports Nutr (2016) 0.75
Acute effects of light and dark roasted coffee on glucose tolerance: a randomized, controlled crossover trial in healthy volunteers. Eur J Nutr (2015) 0.75
The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab (2010) 3.11
Inflammasome is a central player in the induction of obesity and insulin resistance. Proc Natl Acad Sci U S A (2011) 2.92
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med (2006) 2.86
Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability. Shock (2005) 2.20
Gender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteers. Crit Care Med (2007) 2.18
Non-invasive quantification of the beta cell mass by SPECT with ¹¹¹In-labelled exendin. Diabetologia (2014) 2.00
A new-generation ultra-long-acting basal insulin with a bolus boost compared with insulin glargine in insulin-naive people with type 2 diabetes: a randomized, controlled trial. Diabetes Care (2011) 1.78
Clinical relevance of drug-drug interactions : a structured assessment procedure. Drug Saf (2005) 1.74
Sympathoinhibition by atorvastatin in hypertensive patients. Circ J (2010) 1.58
Glyburide inhibits dipyridamole-induced forearm vasodilation but not adenosine-induced forearm vasodilation. Clin Pharmacol Ther (2004) 1.54
The inflammasome puts obesity in the danger zone. Cell Metab (2012) 1.49
Acute and long-term cardiovascular effects of coffee: implications for coronary heart disease. Pharmacol Ther (2008) 1.46
The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens (2002) 1.42
Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia. Cardiovasc Res (2003) 1.42
Vascular adaptation to deconditioning and the effect of an exercise countermeasure: results of the Berlin Bed Rest study. J Appl Physiol (1985) (2005) 1.36
Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue. Diabetes (2011) 1.35
Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2011) 1.27
Annexin A5 scintigraphy of forearm as a novel in vivo model of skeletal muscle preconditioning in humans. Circulation (2004) 1.26
Vascular adaptation to 4 wk of deconditioning by unilateral lower limb suspension. Am J Physiol Heart Circ Physiol (2004) 1.26
The bilirubin-increasing drug atazanavir improves endothelial function in patients with type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol (2010) 1.25
Upregulation of renal inducible nitric oxide synthase during human endotoxemia and sepsis is associated with proximal tubule injury. Clin J Am Soc Nephrol (2006) 1.17
Vildagliptin improves endothelium-dependent vasodilatation in type 2 diabetes. Diabetes Care (2011) 1.15
Enhanced endothelin-1-mediated leg vascular tone in healthy older subjects. J Appl Physiol (1985) (2007) 1.15
Metformin prevents myocardial reperfusion injury by activating the adenosine receptor. J Cardiovasc Pharmacol (2009) 1.13
Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases. Ann Rheum Dis (2007) 1.10
Modulation of innate immunity by adenosine receptor stimulation. Shock (2011) 1.08
Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training. Aging Cell (2006) 1.07
Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia. J Endotoxin Res (2005) 1.05
Influence of body and arm position on blood pressure readings: an overview. J Hypertens (2003) 1.04
Enhancing evidence-based advice of occupational health physicians. Scand J Work Environ Health (2007) 1.04
The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue. Endocrinology (2011) 1.04
Caffeine prevents protection in two human models of ischemic preconditioning. J Am Coll Cardiol (2006) 1.03
In vivo evidence against a role for adenosine in the exercise pressor reflex in humans. J Appl Physiol (1985) (2005) 1.02
Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology. Diabetes Care (2011) 1.00
Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes (2012) 0.99
Rapid vascular adaptations to training and detraining in persons with spinal cord injury. Arch Phys Med Rehabil (2006) 0.99
A single-base mutation in the peroxisome proliferator-activated receptor gamma4 promoter associated with altered in vitro expression and partial lipodystrophy. J Clin Endocrinol Metab (2004) 0.98
In vivo evidence for nitric oxide-mediated calcium-activated potassium-channel activation during human endotoxemia. Circulation (2006) 0.98
Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia? Clin Endocrinol (Oxf) (2009) 0.97
Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia. J Clin Invest (2013) 0.97
Sympathetic nervous system contributes to the age-related impairment of flow-mediated dilation of the superficial femoral artery. Am J Physiol Heart Circ Physiol (2006) 0.97
Microvascular permeability during experimental human endotoxemia: an open intervention study. Crit Care (2005) 0.94
Liraglutide reverses pronounced insulin-associated weight gain, improves glycaemic control and decreases insulin dose in patients with type 2 diabetes: a 26 week, randomised clinical trial (ELEGANT). Diabetologia (2014) 0.94
Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients. J Clin Endocrinol Metab (2009) 0.93
Dipyridamole augments the antiinflammatory response during human endotoxemia. Crit Care (2011) 0.92
Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia. Hypertension (2010) 0.92
Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab (2005) 0.91
Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans. J Cardiovasc Pharmacol (2012) 0.90
The effect of the interleukin-1 cytokine family members IL-1F6 and IL-1F8 on adipocyte differentiation. Obesity (Silver Spring) (2010) 0.90
A causal role for endothelin-1 in the vascular adaptation to skeletal muscle deconditioning in spinal cord injury. Arterioscler Thromb Vasc Biol (2006) 0.90
Preserved contribution of nitric oxide to baseline vascular tone in deconditioned human skeletal muscle. J Physiol (2005) 0.89
Preserved alpha-adrenergic tone in the leg vascular bed of spinal cord-injured individuals. Circulation (2003) 0.89
Theophylline improves hypoglycemia unawareness in type 1 diabetes. Diabetes (2002) 0.89
Rosuvastatin increases extracellular adenosine formation in humans in vivo: a new perspective on cardiovascular protection. Arterioscler Thromb Vasc Biol (2009) 0.89
Increased insulin requirements during exercise at very high altitude in type 1 diabetes. Diabetes Care (2011) 0.89
Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans. Clin Pharmacol Ther (2005) 0.88
Reproducibility of blood flow and post-occlusive reactive hyperaemia as measured by venous occlusion plethysmography. Clin Sci (Lond) (2005) 0.88
Adaptive changes of mesenteric arteries in pregnancy: a meta-analysis. Am J Physiol Heart Circ Physiol (2012) 0.87
The 22G>A polymorphism in the adenosine deaminase gene impairs catalytic function but does not affect reactive hyperaemia in humans in vivo. Pharmacogenet Genomics (2008) 0.87
Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study. Cardiovasc Diabetol (2012) 0.87
The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial. Exp Gerontol (2013) 0.87
Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene. Eur Heart J (2007) 0.87
Sympathoinhibitory effect of statins in chronic heart failure. Clin Auton Res (2009) 0.87
Caspase-1 deficiency in mice reduces intestinal triglyceride absorption and hepatic triglyceride secretion. J Lipid Res (2012) 0.87
The cardiovascular effects of methylxanthines. Handb Exp Pharmacol (2011) 0.87
Impaired vascular responses to relaxin in diet-induced overweight female rats. J Appl Physiol (1985) (2011) 0.86
F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients. AIDS (2004) 0.86
Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans. Clin Pharmacol Ther (2003) 0.86
Unilateral lower limb suspension can cause deep venous thrombosis. Am J Physiol Regul Integr Comp Physiol (2004) 0.86
Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness. J Clin Endocrinol Metab (2006) 0.85
Glycogen synthesis in human gastrocnemius muscle is not representative of whole-body muscle glycogen synthesis. Diabetes (2005) 0.85
Atrial natriuretic peptide-induced microalbuminuria is associated with endothelial dysfunction in noncomplicated type 1 diabetes patients. Am J Kidney Dis (2002) 0.85
Aging attenuates the vasodilator response to relaxin. Am J Physiol Heart Circ Physiol (2011) 0.85
Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation. Diabetes Metab Res Rev (2004) 0.85
Human in vivo research on the vascular effects of adenosine. Eur J Pharmacol (2008) 0.85
Improving myocardial perfusion by percutaneous coronary intervention reduces central sympathetic activity in stable angina. Clin Cardiol (2010) 0.85
The effect of adenosine receptor agonists on cytokine release by human mononuclear cells depends on the specific Toll-like receptor subtype used for stimulation. Cytokine (2006) 0.85
Role of NO in endothelin-regulated drug transport in the renal proximal tubule. Am J Physiol Renal Physiol (2002) 0.84
Glibenclamide depletes ATP in renal proximal tubular cells by interfering with mitochondrial metabolism. Br J Pharmacol (2005) 0.84
Enhanced cellular adenosine uptake limits adenosine receptor stimulation in patients with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol (2004) 0.84
A novel insulin combination of insulin degludec and insulin aspart achieves a more stable overnight glucose profile than insulin glargine: results from continuous glucose monitoring in a proof-of-concept trial. J Diabetes Sci Technol (2013) 0.84
Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH). Curr Med Res Opin (2005) 0.84
Role of endogenous vascular endothelial growth factor in endothelium-dependent vasodilation in humans. Hypertension (2013) 0.84
Intravenous AICAR during hyperinsulinemia induces systemic hemodynamic changes but has no local metabolic effect. J Clin Pharmacol (2010) 0.83
Adult patients with congenital adrenal hyperplasia have elevated blood pressure but otherwise a normal cardiovascular risk profile. PLoS One (2011) 0.83
Plasma obtained during human endotoxemia increases endothelial albumin permeability in vitro. Shock (2006) 0.83
Short-term exposure of renal proximal tubules to gentamicin increases long-term multidrug resistance protein 2 (Abcc2) transport function and reduces nephrotoxicant sensitivity. J Pharmacol Exp Ther (2005) 0.82
Upregulation of skeletal muscle inflammatory genes links inflammation with insulin resistance in women with the metabolic syndrome. Exp Physiol (2013) 0.82
The effect of acute exercise on glycogen synthesis rate in obese subjects studied by 13C MRS. Eur J Appl Physiol (2010) 0.82
Acute elevation of plasma non-esterified fatty acids increases pulse wave velocity and induces peripheral vasodilation in humans in vivo. Clin Sci (Lond) (2007) 0.82
Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes. Diabetes Care (2013) 0.82